Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-25 4:05 pm Purchase | 2025-02-18 | 13G | Solid Biosciences Inc. SLDB | Commodore Capital LP | 5,825,000 7.600% | 5,825,000 (New Position) | Filing History |
| 2025-02-21 6:04 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 6,179,042 7.800% | 3,877,087 (+168.43%) | Filing History |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 7,989,820 9.900% | 3,631,342 (+83.32%) | Filing History |
| 2025-02-21 4:15 pm Purchase | 2025-02-19 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 11,934,679 15.600% | 5,000,001 (+72.10%) | Filing History |
| 2025-02-14 08:30 am Sale | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Camber Capital Management LP | 0 0.000% | -1,418,440 (Position Closed) | Filing History |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 3,749,041 9.400% | 1,000,000 (+36.38%) | Filing History |
| 2024-11-14 7:59 pm Purchase | 2024-11-14 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% | 6,934,678 (New Position) | Filing History |
| 2024-11-14 12:02 pm Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Vestal Point Capital, LP | 2,800,000 7.300% | 2,800,000 (New Position) | Filing History |
| 2024-11-14 08:56 am Sale | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Flynn James E | 0 0.000% | -2,260,398 (Position Closed) | Filing History |
| 2024-11-12 4:58 pm Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 2,749,041 7.100% | 240,898 (+9.60%) | Filing History |
| 2024-11-12 09:30 am Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Adage Capital Management L.P. | 1,754,159 4.550% | 1,754,159 (New Position) | Filing History |
| 2024-11-01 4:10 pm Sale | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Millennium Management LLC | 1,117,097 2.900% | -896,840 (-44.53%) | Filing History |
| 2024-08-02 6:37 pm Purchase | 2024-07-25 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 2,508,143 6.500% | 2,508,143 (New Position) | Filing History |
| 2024-06-12 6:26 pm Purchase | 2024-06-11 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 4,358,478 11.300% | 9,650 (+0.22%) | Filing History |
| 2024-06-11 8:43 pm Unchanged | 2024-06-07 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 2,301,955 6.000% | 0 (Unchanged) | Filing History |
| 2024-06-05 4:12 pm Purchase | 2024-05-30 | 13G | Solid Biosciences Inc. SLDB | Millennium Management LLC | 2,013,937 5.200% | 2,013,937 (New Position) | Filing History |
| 2024-02-07 5:22 pm Purchase | 2024-01-08 | 13G | Solid Biosciences Inc. SLDB | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,712,478 7.250% | 2,712,478 (New Position) | Filing History |
| 2024-01-22 4:31 pm Purchase | 2024-01-11 | 13G | Solid Biosciences Inc. SLDB | Artal International S.C.A. | 2,717,538 7.300% | 2,717,538 (New Position) | Filing History |
| 2024-01-12 5:11 pm Purchase | 2024-01-11 | 13D | Solid Biosciences Inc. SLDB | PERCEPTIVE ADVISORS LLC | 6,925,028 18.600% | 3,423,763 (+97.79%) | Filing History |
| 2024-01-12 5:05 pm Unchanged | 2024-01-11 | 13D | Solid Biosciences Inc. SLDB | BCLS SB Investco LP | 2,301,955 6.200% | 0 (Unchanged) | Filing History |